The UK is witnessing a growing surge in interest surrounding entheogenic substances. Beyond the common use of psilocybin and LSD, investigators and enthusiasts are increasingly focused on less-charted areas, particularly copyright and the nascent cannabinoid, CBG compound. This expanding movement